No. 1 heart hospital in US announces key changes to its cardiology leadership
NYU Langone Health in New York City, ranked the No. 1 heart hospital in the United States for two years in a row, has announced some major changes to its leadership structure.
Sunil Rao, MD, known all over the world for his work as a researcher and interventional cardiologist, is taking over as the new director of the hospital’s Leon H. Charney Division of Cardiology. He replaces Glenn I. Fishman, MD, who is stepping down from the role after spending the 25 years as a hospital leader. Fishman will still serve NYU Langone Health as a member of the hospital’s faculty.
Rao previously served as NYU Langone’s director of interventional cardiology, helping guide its busy cath labs. He was also president of the Society for Cardiovascular Angiography and Interventions in 2022-2023.
“I am honored to serve as director of this division alongside such extraordinary faculty, trainees, and staff,” Rao said in a statement. “Cardiovascular medicine is entering an exciting era of discovery, with new technologies and treatments creating opportunities to improve care for more patients. I look forward to continuing to work with colleagues across NYU Langone and beyond to translate innovation into better outcomes for the communities we serve.”
“Serving as director of the Leon H. Charney Division of Cardiology has been one of the greatest privileges of my career,” added Fishman. “I am incredibly proud of what our faculty, trainees and staff have accomplished together, and I look forward to continuing to contribute to the research, education and mentorship missions of the division and department of medicine.”
Meanwhile, NYU Langone Health has announced that Susheel K. Kodali, MD, a veteran interventional cardiologist who spent many years with nearby NewYork-Presbyterian/Columbia University Irving Medical Center, will serve as Rao’s replacement as its director of interventional cardiology. Kodali is a known leader in structural heart disease, especially when it comes to transcatheter aortic valve replacement and other interventional procedures for the treatment of heart valve disease.
“I am thrilled to join the NYU Langone Heart community and collaborate with colleagues who share a commitment to advancing what is possible in cardiovascular care,” Kodali said in the same statement. “Structural heart disease has transformed how we treat many patients, and I look forward to working with teams across the health system to further expand access to these therapies.”
Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.